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Abstract
In the present study, we investigated whether n-6 and n-3 long-chain PUFA (LC-PUFA) concentrations in cord blood (CB) serum are
associated with BMI up to 10 years of age, after accounting for LC-PUFA composition at 2, 6 and 10 years. The study was based on
388 participants of the German LISAplus (Influence of Lifestyle-Related Factors on the Immune System and the Development of Allergies
in Childhood Plus the Influence of Traffic Emissions and Genetics) birth cohort study carried out in Munich. BMI was measured at 2, 6 and
10 years of age. Serum phospholipid fatty acid concentrations were measured by GC in CB and in blood collected at 2, 6 and 10 years of
age. The association between n-3 LC-PUFA and n-6 LC-PUFA concentrations and n-6:n-3 LC-PUFA ratio in CB serum glycerophospholipids
and BMI z-scores was assessed using linear mixed models adjusted for LC-PUFA composition at follow-up and potential confounders.
Interaction terms between time of follow-up and LC-PUFA concentrations in CB were included. There was no consistent association
between n-6 and n-3 LC-PUFA concentrations in CB and BMI over time. However, there was a significant interaction between n-6:n-3
LC-PUFA ratio in CB and time of follow-up with respect to BMI (P¼0·0415): a negative effect at 2 years; no effect at 6 years; a positive
effect at 10 years. BMI up to 10 years of age may be influenced by the n-6:n-3 ratio in CB serum glycerophospholipids in a time-varying
fashion. The present results thereby highlight the importance of considering age when examining associations between fatty acid concen-
trations and BMI.
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The prevalence of overweight and obesity in children has
increased over the past few decades. Early-life obesity is an
emerging risk factor for obesity and obesity-related diseases
in adulthood(1–3). In addition to other factors, altered fatty
acid composition in diet, especially an elevated ratio of
n-6:n-3 long-chain PUFA (LC-PUFA), has been suggested to
be a potential contributing factor(4,5).
Adipocyte development and fat deposition in the fetus
increase exponentially with gestational age(6). During the
last trimester of gestation, LC-PUFA accumulate in the
placenta(6,7), leading to higher concentrations of LC-PUFA in
cord blood (CB) than in maternal plasma. CB LC-PUFA
concentrations are associated with maternal dietary intake
and maternal LC-PUFA concentrations in plasma(8,9).
Postnatally, the increase in the number and size of
adipocytes is highest during the first year of life, although
the differentiation of precursor cells into adipocytes also con-
tinues later in life(5,7). Thus, prenatal and early postnatal
periods are critical for adipose tissue development.
Ailhaud et al.(5,10) proposed that the qualitative changes in
ingested fats, specifically the increased intake of n-6 PUFA,
which yields a higher n-6:n-3 ratio, may promote adipose
tissue development. Arachidonic acid (AA), the main n-6
PUFA metabolite, is a precursor of eicosanoids, such as pros-
tacyclin. Prostacyclin enhances the differentiation of adipose
precursor cells into adipocytes. By contrast, the n-3 LC-PUFA
EPA and DHA attenuate the production of eicosanoids and,
therefore, are less adipogenic and inhibit adipose tissue
development(5,10).
So far, despite a biologically plausible mechanism, evidence
for an association between CB LC-PUFA composition and adi-
pose tissue development is scarce. In 2010, a Cochrane review
of interventional studies on the effect of LC-PUFA supplemen-
tation in breast-feeding mothers on child growth has led to a
conclusion of insufficient evidence for this association(11).
No association between LC-PUFA supplementation and
weight has been found, but a negative association between
LC-PUFA supplementation and child length has been found.
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A more recently published review has also led to inconclusive
results(12), despite two of the reviewed interventional studies
reporting a modest increase in birth weight associated with
maternal n-3 LC-PUFA supplementation. The INFAT (impact of
nutritional fatty acids during pregnancy and lactation on early
adipose tissue development) study, which investigated the
effect of n-3 fatty acid supplementation during pregnancy and
lactation period on adipose tissue growth during the first year
of life, found no effects. However, this study was limited by
sample size, as only approximately 100 subjects were included
in each group(13). This sample size was required based on a cal-
culation with ana-level of 5 and 80% power to detect differences
of at least 5mm in the sum of four defined skinfolds between the
intervention and control groups at 4 months(14).
In the present study, we aimed to investigate how the
concentrations of n-3 LC-PUFA and n-6 LC-PUFA and the
ratio of n-6:n-3 LC-PUFA in CB serum glycerophospholipids
affect BMI later in life using a longitudinal study design
based on repeated BMI and LC-PUFA measurements. The con-
centrations of n-3 LC-PUFA and n-6 LC-PUFA and the ratio of
n-6:n-3 LC-PUFA at follow-up examinations later in life were
included in the analysis to rule out confounding by lifestyle
or dietary factors, which may be reflected in the fatty acid
composition in blood. We hypothesise that higher n-3
LC-PUFA concentrations, lower n-6 LC-PUFA concentrations
and a lower n-6:n-3 LC-PUFA ratio in CB serum glycerophos-
pholipids are associated with a lower BMI up to 10 years
of age, even after accounting for serum glycerophospholipid
LC-PUFA concentrations later in life.
Subjects and methods
Study population
The German LISAplus (Influence of Lifestyle-Related Factors
on the Immune System and the Development of Allergies in
Childhood Plus the Influence of Traffic Emissions and
Genetics) is a population-based birth cohort study in which
a total of 3097 neonates were recruited between 1997 and
1999 from the German cities of Munich, Leipzig, Wesel and
Bad Honnef. Details of the study design have been described
elsewhere(15). During recruitment in maternity wards, CB
samples were collected and deep-frozen until the time of
measurement. Questionnaires were completed by the parents
at birth and 0·5, 1, 1·5, 2, 4, 6 and 10 years of age, and physical
examinations took place at 2, 6 and 10 years. During the
physical examinations, blood samples were collected and
height and weight were measured.
Participant flow is shown in Fig. 1. The substudy was
restricted to children from the Munich study centre. Of the
1467 successfully recruited children, CB samples could be
collected from 814. These 814 CB samples were used to
measure total IgE concentrations(15), and a sufficient amount
of serum collected from 681 children remained for the
measurement of fatty acid composition. Fatty acid compo-
sition was measured in these remaining 681 CB samples.
Approval from the local ethics committees (Bavarian Board
of Physicians, University of Leipzig, Board of Physicians
of North Rhine-Westphalia) and written consent from the
participants’ families were obtained.
Calculation of BMI z-scores
BMI was calculated during each follow-up at 2, 6 and 10 years
of age and transformed to age- and sex-specific standard
deviation scores (z-scores) according to the WHO growth
standards(16).
Measurement of fatty acid concentrations
Fatty acid analysis was carried out by selective transfer of
glycerophospholipid fatty acids from 100ml serum into their
methyl esters and their gas chromatographic separation and
quantification(17). This procedure has been described pre-
viously in detail for the analysis of serum from CB and from
blood samples collected at the ages of 2 and 6 years(18,19)
and has also been applied for blood samples collected at
the age of 10 years.
Total n-6 LC-PUFA concentration was calculated by sum-
ming up eicosadienoic acid (20 : 2n-6), dihomo-g-linolenic








Children with CB sample 






due to missing covariates
No participation in follow-up
examinations
(n 266)
CB samples only for
IgE measurement(15)
(n 814)
Wesel, Bad Honnef and
Leipzig study centres
(n 1630)
Birth:           n 4 (n-6 LC-PUFA) 
2 years:       n 4 (n-3 LC-PUFA) 
6 years:       n 2 (n- 3 LC-PUFA) 
10 years:     n 2 (zBMI) 
n 1 (n-3 LC-PUFA) 
n 1 (n-6:n-3 ratio) 
Exclusion of outliers (>±4SD):
2 years (n 184)
6 years (n 265)
10 years (n 230)
Fig. 1. Participant flow. LISAplus birth cohort, Influence of Lifestyle-Related
Factors on the Immune System and the Development of Allergies in Child-
hood Plus the Influence of Traffic Emissions and Genetics birth cohort; CB,
cord blood; LC-PUFA, long-chain-PUFA; zBMI, BMI z-scores.
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docosapentaenoic acid (22 : 5n-6) concentrations. Total n-3
LC-PUFA concentration was calculated by summing up eico-
satrienoic acid (20 : 3n-3), EPA (20 : 5n-3), docosapentaenoic
acid (22 : 5n-3) and DHA (22 : 6n-3) concentrations. Total n-6
LC-PUFA and total n-3 LC-PUFA concentrations are presented
as a percentage of the concentrations of all the measured fatty
acids with fourteen to twenty-four carbon atoms. The n-6:n-3
LC-PUFA ratio was calculated by dividing total n-6 LC-PUFA
concentrations by total n-3 LC-PUFA concentrations.
Statistical analyses
Children with BMI z-scores (zBMI) or fatty acid concentrations
deviating more than ^4 SD from the mean were considered as
outliers and treated as missing values in the respective analysis
(Fig. 1). This affected at birth four children for n-6 LC-PUFA
concentrations, at 2 years four children for n-3 LC-PUFA
concentrations, at 6 years two children for n-3 LC-PUFA con-
centrations, and at 10 years two children for zBMI, one child
for n-3 LC-PUFA concentrations and one child for n-6:n-3
LC-PUFA ratio. All the investigated variables were tested for
differences between study participants and non-participants
using Fisher’s exact test for binary variables, Wilcoxon rank-
sum test for continuous, not normally distributed variables
and two-sample t test for normally distributed variables.
Correlations between repeated measurements of zBMI, n-6
LC-PUFA concentrations, n-3 LC-PUFA concentrations and
n-6:n-3 LC-PUFA ratio were determined and tested using
Pearson’s correlation.
Linear mixed models, which are an extension of linear
regression to longitudinal data, were applied to account for
the repeated zBMI measurements(20). A random intercept
was included in the model for each subject, which modelled
the change per individual over time. As such, the same
number of measurements per subject was not required.
Inclusion criteria for this analysis were the availability of
information on CB LC-PUFA composition and on zBMI and
LC-PUFA measurements for at least one of the follow-up
time points (2, 6 or 10 years). The model included variables
that were the same for each time point (LC-PUFA composition
in CB, birth weight, maternal BMI before pregnancy (subjects
with a BMI .46 kg/m2 were excluded) and exclusive breast-
feeding (defined as a binary variable: exclusive breast-feeding
for at least 4 months v. no exclusive breast-feeding or exclu-
sive breast-feeding for ,4 months)) as well as time-varying
variables (age, time of follow-up and LC-PUFA composition
at 2, 6 and 10 years). The linear mixed models returned
one estimate for the variables that were measured once
(CB LC-PUFA composition) and one combined estimate for
the variables that were measured at the various time points
(LC-PUFA composition at follow-up).
Based on the results of initial explanatory analyses, three
interaction terms were included in the model (between time
of follow-up and LC-PUFA composition in CB, LC-PUFA con-
centrations at the time of follow-up and maternal BMI
before pregnancy). Additionally, maternal age at birth, maternal
education level (low: less than tenth grade; medium: tenth
grade; and high: more than tenth grade), maternal smoking
during pregnancy, parity (defined as number of pregnancies;
coded as 0 if the child under study was firstborn and 1 other-
wise) and sex were tested as covariables, but these did not
exhibit a significant association in the fully adjusted model
and were therefore not included in the final model. Statistical
significance was defined by a two-sided a-level of 5 %.
Additionally, linear regression was conducted for each
follow-up, regressing LC-PUFA composition in CB on zBMI
adjusted for LC-PUFA composition at the time of follow-up,
age, birth weight, maternal BMI before pregnancy and exclu-
sive breast-feeding for at least 4 months.
The linear mixed model does not require that each subject
have the same number of data points. To rule out a potential
bias that may be introduced by non-random loss to follow-up,
Table 1. Characteristics of the study population









Mean SD Mean SD Mean SD Mean SD
Age (years) 2·0 0·0 6·1 0·2 10·2 0·2
zBMI 0·2 1·0 0·0 0·90 0·0 1·0
n-6 LC-PUFA (%)* 25·3 1·5 13·4 1·5 13·7 1·6 15·0 1·6
n-3 LC-PUFA (%)* 8·1 1·6 4·5 0·8 4·5 0·9 4·8 1·0
n-6:n-3 LC-PUFA ratio* 3·2 0·7 3·0 0·5 3·1 0·6 3·2 0·6
Sex (female) (%) 43·6
Maternal BMI (kg/m2) 22·2 3·4
Birth weight (g) 3429·3 391·1
Exclusive breast-feeding for .4 months (%) 49·5
Maternal age (years) 32·8 4·0
Smoking during pregnancy (%) 11·6




Parity (%; firstborn) 50·1
CB, cord blood; zBMI, BMI z-scores; LC-PUFA, long-chain-PUFA.
* Measured in serum glycerophospholipids.
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an additional sensitivity analysis was conducted. This analysis
was restricted to children with complete information on zBMI
and fatty acid measurements at all time points.
Statistical analyses were carried out using R, version 2.15.2
(www.R-project.org)(21). The linear mixed models were calcu-
lated using the lmer() function from the ‘lme4’ package(22),
and the ‘effects’ package was used for plotting(23).
Results
Complete information on n-3 and n-6 LC-PUFA concentrations
or n-6:n-3 LC-PUFA ratio in CB serum glycerophospholipids
and zBMI and LC-PUFA composition in serum glycerophos-
pholipids at one or more follow-ups at 2, 6 or 10 years of
age, as well as all covariables, was available for 388 children.
To investigate the effect of selective dropout, all variables
were tested for differences between participants and non-
participants (Supplementary Table S1, available online), and
none was found to differ significantly.
The basic characteristics of the study population are sum-
marised in Table 1. The percentage of LC-PUFA was higher
in CB serum glycerophospholipids, although the n-6:n-3
LC-PUFA ratio remained stable. LC-PUFA concentrations
increased slightly with age.
Tables 2–5 summarise the correlations between time
of follow-up and zBMI, n-6 LC-PUFA concentrations, n-3
LC-PUFA concentrations and n-6:n-3 LC-PUFA ratio. zBMI
measurements at 2, 6 and 10 years of age were positively
correlated and reached statistical significance (Table 2). The
lowest correlation was observed between 2 and 10 years of
age (Pearson’s correlation coefficient r 0·2) and the highest
between 6 and 10 years of age (r 0·64). CB n-6 LC-PUFA con-
centrations were weakly, but significantly associated with n-6
LC-PUFA concentrations at 2 years (r 0·14) and 6 years (r 0·13)
of age, but this result was no longer significant at 10 years
(Table 3). Blood n-6 LC-PUFA concentrations at 2, 6 and
10 years of age were moderately correlated (r 0·45–0·53).
For n-3 LC-PUFA concentrations and n-6:n-3 LC-PUFA ratio,
the correlation pattern was similar, although the correlation
coefficients were smaller (Tables 4 and 5).
Results obtained from the linear mixed models for zBMI are
given in Table 6. The concentrations of n-6 LC-PUFA and n-3
LC-PUFA or the ratio of n-6:n-3 LC-PUFA in CB was not signifi-
cantly associated with zBMI later in life. The interaction term
between time of follow-up and n-6:n-3 LC-PUFA ratio in CB
was significant (P¼0·0415). Fig. 2 shows the interaction
effect between time of follow-up and n-6:n-3 LC-PUFA ratio
in CB: a negative effect of the n-6:n-3 LC-PUFA ratio in CB
was observed at 2 years; no effect was observed at 6 years;
a positive effect was observed at 10 years. The interaction
effects between n-6 and n-3 LC-PUFA concentrations in CB
and time of follow-up were not significant (P¼0·1764 and
0·1870, respectively). The effect of CB n-6 LC-PUFA concen-
trations was in the same direction (Supplementary Fig. S1(a),
available online) as the interaction effect of n-6:n-3 LC-PUFA
ratio in CB, whereas the effect of CB n-3 LC-PUFA was in
the opposite direction (Supplementary Fig. S2(a), available
online).
However, when the time-varying variables from the same
year of follow-up were considered (Table 6), n-6 LC-PUFA
concentrations were found to be associated with zBMI
(b ¼ 0·02, P,0·0429). The association for n-3 LC-PUFA con-
centrations or the n-6:n-3 LC-PUFA ratio was not significant
(b ¼ 20·18, P¼0·2813, and b ¼ 0·28, P¼0·999, respectively).
Additionally, there was a significant interaction between time
of follow-up and n-6 and n-3 LC-PUFA concentrations at the
time of follow-up (P¼0·0009 and 0·0028, respectively), but
not the n-6:n-3 LC-PUFA ratio at the time of follow-up
(P¼0·1356; Supplementary Fig. S3, available online).
Supplementary Figs. S1(b) and S2(b) (available online)
show the interaction effect between time of follow-up and
n-6 and n-3 LC-PUFA concentrations at the time of follow-
up, respectively. The concentrations of n-6 LC-PUFA exhibited
a modest effect on zBMI at 2 and 6 years of age, whereas there
was a strong positive effect at 10 years, indicating that children
with a higher zBMI do have higher n-6 LC-PUFA concen-
trations (Supplementary Fig. S1(b), available online). The con-
centrations of n-3 LC-PUFA had a negative effect at 2 years, no
effect at 6 years and a positive effect at 10 years of age
(Supplementary Fig. S2(b), available online).
These results were further confirmed by stratified analyses
using linear regression for each follow-up (Supplementary
Table S2, available online). The direction of effect was the
same as that of the interaction terms in the linear mixed
models, although not all effects reached significance due to
a reduced sample size.
In an additional sensitivity analysis, the linear mixed models
were restricted to children with complete information on zBMI
and fatty acid measurements at all time points (Supplementary
Table S3, available online). The effect estimates were in the
same direction of effect, although significance was not
reached probably due to a reduced sample size (seventy-
four children).
Table 2. Pearson’s correlation between time
of follow-up and BMI z-scores (zBMI)
zBMI 2 years 6 years 10 years
2 years 1
6 years 0·52*** 1
10 years 0·20* 0·75*** 1
*P,0·05, ***P,0·001.
Table 3. Pearson’s correlation between time of follow-up and
n-6 long-chain PUFA (LC-PUFA) concentrations†
n-6 LC-PUFA CB 2 years 6 years 10 years
CB 1
2 years 0·14* 1
6 years 0·13* 0·43*** 1
10 years 0 0·47*** 0·51*** 1
CB, cord blood.
*P,0·05, ***P,0·001.
† Measured in serum glycerophospholipids.
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Discussion
The present study investigated the association between n-3
and n-6 LC-PUFA concentrations and n-6:n-3 LC-PUFA ratio
in CB serum glycerophospholipids and zBMI at 2, 6 and
10 years of age, after accounting for LC-PUFA percentages in
serum glycerophospholipids using longitudinal data from the
Munich LISAplus birth cohort.
The n-6:n-3 LC-PUFA ratio or n-6 and n-3 LC-PUFA concen-
trations in CB serum phospholipids were not consistently
associated with zBMI. However, there was a significant
interaction between n-6:n-3 LC-PUFA ratio in CB and time of
follow-up with respect to zBMI. A negative effect was
observed at 2 years, no effect was observed at 6 years and a
positive effect was observed at 10 years of age. The effect of
n-6 LC-PUFA concentrations was in the same direction and
that of n-3 LC-PUFA concentrations was in the opposite direc-
tion, but both were not significant.
When variables collected at the same time point were
entered into the models, a higher zBMI was found to be
associated with higher n-6 LC-PUFA percentages in serum
glycerophospholipids, whereas the interaction effect between
n-6 LC-PUFA concentrations and time of follow-up indicated
that this effect was strongest at 10 years of age. The interaction
term between n-3 LC-PUFA concentrations and time of
follow-up suggests a positive effect on zBMI at 10 years, but
a negative effect at 2 years of age.
Cross-sectional studies suggest that obese subjects have
lower concentrations of n-3 LC-PUFA(24,25). Therefore, studies
have mainly focused on the supplementation of pregnant or
breast-feeding women to improve the n-3 LC-PUFA supply
to the offspring(13,26–31). These interventional studies have
led to inconclusive results. Courville et al.(26) reported lower
ponderal indices at birth in an intervention group (n 22)
receiving a DHA-containing functional food containing
300 mg of DHA from mid-pregnancy to delivery compared
with those in the control group (n 25) consuming a placebo
bar containing maize oil. Another study carried out by
Asserhøj et al.(27) allocated women to high-fish intake (n 53)
or low-fish intake (n 122) groups, and the women in the
low-intake group were further allocated to receive fish-oil sup-
plements containing 0·6 g EPA/d and 0·8 g DHA/d (n 62), or a
control group supplemented with olive oil (n 60) from delivery
to 4 months of lactation. The authors found a higher BMI in the
supplementation group at 2·5 years, but this effect was no longer
apparent at 7 years of age(27). A supplementation study in
144 mothers randomised to receive one of three vitamin–
mineral supplements, of which one was supplying additional
200 mg DHA/d, from mid-pregnancy to 3 months conducted
by Bergmann et al.(29) found lower BMI and weight values
in the infants allocated to the intervention group at 21
months of age, but there was no longer a difference between
the intervention and control groups at 6 years of age(30).
Rosenfeld et al.(28) conducted a meta-analysis based on
individual patient data from four randomised clinical trials of
postnatal supplementation with formula milk with and
without LC-PUFA (DHA and AA). There was no difference in
weight, length, head circumference or BMI between 442
supplemented children and 459 control children at
18 months(28). The INFAT Study, a clinical trial, investigated
the effect of detailed nutritional counselling and supple-
mentation with 1200 mg DHA/d from 15th week of gestation
to 4 months after delivery on the offspring’s body composition
assessed at several time points during the first year of life. The
control group received brief semi-structured counselling on a
healthy diet. Although there was a significant increase in n-3
LC-PUFA concentrations and a decrease in AA concentrations
in maternal blood in the intervention group, there were no
significant differences between the intervention and control
groups with regard to any of the investigated growth and
body composition parameters(13). Maternal AA and n-6
LC-PUFA concentrations were inversely associated with BMI
at 1 year of age, but not with fat mass(31). A randomised
controlled intervention study carried out by Andersen
et al.(32) investigated the effect of fish oil (1·6 g EPA þ DHA/d)
v. sunflower oil in 133 infants from 9 to 18 months of age.
There was no significant difference in any of the anthropometric
measures related to fat mass, but the infants in the sunflower
group had a lower skinfold ratio (tricipital:subscapular) at
18 months of age.
Donahue et al.(33) reported results from an observational
study that investigated associations between childhood obes-
ity at 3 years of age and maternal dietary intake and maternal
plasma fatty acid composition during pregnancy, as well as CB
PUFA concentrations. Obesity (BMI $95th percentile) and the
sum of skinfold thicknesses were negatively associated with
CB n-3 LC-PUFA concentrations and positively associated
with the n-6:n-3 LC-PUFA ratio. zBMI were associated with
maternal plasma total n-6 LC-PUFA concentrations but not
with CB PUFA concentrations.
Table 4. Pearson’s correlation between time of follow-up and
n-3 long-chain PUFA (LC-PUFA) concentrations†
n-3 LC-PUFA CB 2 years 6 years 10 years
CB 1
2 years 0·13* 1
6 years 0·09 0·32*** 1
10 years 0·1 0·27** 0·35*** 1
CB, cord blood.
*P,0·05, **P,0·01, ***P,0·001.
† Measured in serum glycerophospholipids.
Table 5. Pearson’s correlation between time of follow-up and n-6:n-3
long-chain PUFA (LC-PUFA) ratio‡
n-6:n-3 LC-PUFA ratio CB 2 years 6 years 10 years
CB 1
2 years 0·15* 1
6 years 0·11† 0·39*** 1




‡ Measured in serum glycerophospholipids.
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Another observational study carried out by Moon et al.(34)
investigated the association between maternal plasma PUFA
concentrations and fat mass and lean mass at 4 and 6 years
of age. Higher maternal plasma n-6 PUFA concentrations
were related to higher offspring fat mass at 4 years and
6 years of age, but not with lean mass. There was no effect
of maternal n-3 PUFA concentrations. Moon et al.(34)
suggested that reducing n-6 LC-PUFA concentrations may be
a more effective method to reduce BMI than increasing n-3
LC-PUFA concentrations.
In summary, observational and interventional studies have
yielded an inconsistent picture of the association between
LC-PUFA concentrations in early life and BMI. Most of these
studies suffer from having a small sample size, in particular,
the interventional studies, and fatty acid composition in
blood was usually measured only once. No study has yet
attempted to longitudinally model the association between
repeated LC-PUFA concentrations and BMI.
The present results indicate a time-dependent effect of CB
serum glycerophospholipid LC-PUFA concentrations on BMI.
The ratio of n-6:n-3 LC-PUFA in CB had a negative effect at
2 years, no effect at 6 years and a positive effect at 10 years
of age. Although non-significant, the effect of n-6 LC-PUFA
concentrations in CB was in the same direction and the
effect of n-3 LC-PUFA concentrations in CB serum glycerophos-
pholipids was in the opposite direction. Considering only the
results obtained at 10 years of age, the results are in line with
the hypothesis introduced by Ailhaud & Guesnet(5). However,
consequently, the results reported herein for 2 years of age
go against this hypothesis. At 6 years of age, which is approxi-
mately the time of adiposity rebound, we found no effect.
During childhood, BMI increases from birth up to the adipo-
sity peak, which occurs at approximately 8–9 months of
age. Afterwards, BMI decreases until the point of adiposity
rebound, which occurs within the age range of 5–7 years.
Table 6. Results obtained from the linear mixed models for BMI z-scores (zBMI) v. n-6 long-chain PUFA (LC-PUFA)
concentrations, n-3 LC-PUFA concentrations and n-6:n-3 LC-PUFA ratio in cord blood (CB) (PUFACB) and at follow-up (PUFAF)







b‡ SE P b‡ SE P b‡ SE P
PUFACB 20·04 0·04 0·8050 0·02 0·04 0·7639 20·11 0·09 0·8017
PUFAF§ 0·02 0·04 0·0429* 20·18 0·08 0·2813 0·28 0·13 0·9990
Time6 years £ PUFACBk 0·04 0·05 0·1764 20·03 0·04 0·1870 0·14 0·10 0·0415*
Time10 years £ PUFACBk 0·07 0·05 20·09 0·04 0·27 0·10
Time6 years £ PUFAF§k 20·05 0·05 0·0009* 0·17 0·09 0·0028* 20·32 0·15 0·1356
Time10 years £ PUFAF§k 0·08 0·05 0·32 0·09 20·41 0·15
*P,0·05.
† Measured in serum glycerophospholipids.
‡ Estimates were adjusted for birth weight, maternal BMI before pregnancy, exclusive breast-feeding for .4 months, time of follow-up (2, 6 or
10 years; reference: 2 years) and age at follow-up, respectively.
§ Combined estimate for the LC-PUFA composition at 2, 6 and 10 years of age.
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Fig. 2. Interaction effect between n-6:n-3 ratio in cord blood (CB) serum glycerophospholipids and time of follow-up (2, 6 and 10 years) on BMI z-scores (zBMI).
The represents the effect; the represent the corresponding 95 % CI. P value of the interaction¼0·0415.
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Usually, an early adiposity rebound predicts a higher BMI later
in life(35).
The main limitation of the present study is that detailed
measurements of body composition and fat mass were not
available. These data would have provided more detailed
information on weight status rather than BMI data. However,
it has been shown that the percentage of body fat and BMI
have similar patterns over time(36).
The longitudinal study design allows the effect of CB serum
glycerophospholipid LC-PUFA concentrations on BMI at sev-
eral time points up to 10 years of age to be modelled. Data
on LC-PUFA concentrations were available at birth and 2, 6
and 10 years of age. CB fatty acid composition represents
the fatty acid supply to the fetus before birth. The models
were adjusted for the fatty acid composition in blood at
each follow-up to rule out confounding by lifestyle or dietary
factors, which may be reflected in fatty acid concentrations in
blood. As we were interested in blood fatty acids, we did not
adjust for potential dietary sources. In addition, data on fish
intake were not collected at each follow-up.
The longitudinal approach used increased the statistical
power of the study, as the maximal number of observations
available was included in the models.
Another limitation of the present study is the potential bias
associated with non-random loss to follow-up. However, a sen-
sitivity analysis restricted to children with complete data for all
the time points of follow-up yielded similar results, although
not significant due to the limited sample size (Supplementary
Table S3, available online), and there were no significant differ-
ences in the investigated variables between participants and
non-participants (Supplementary Table S1, available online).
More longitudinal studies are needed to assess the long-
term effect of CB LC-PUFA concentrations on body compo-
sition and weight development. Only with additional studies
will we be able to develop well-justified dietary recommen-
dations during pregnancy.
In summary, BMI up to 10 years of age may be influenced
by the ratio of n-6:n-3 LC-PUFA in CB serum glycerophospho-
lipids. However, this effect appears to vary with age. The pre-
sent results thereby highlight the importance of considering
age when examining associations between fatty acid concen-
trations and BMI.
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